or Try an Advanced Search...

    Ns3 Stocks List

    Symbol Grade Name % Change
    ENTA D Enanta Pharmaceuticals, Inc. -2.60
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Chemical Compounds Cyclophilin Cyclopropanes HCV HCV Infection Hepatitis C Hepatitis C Virus Infection Infectious Diseases Medical Research Methicillin Pyrrolidines Staphylococcus Aureus Treatment Of Hepatitis Viruses

    Related ETFs - A few ETFs which own one or more of the above listed Ns3 stocks.

    Symbol Grade Name Weight
    GERM D ETFMG Treatments Testing and Advancements ETF 0.69
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.47
    SBIO D ALPS Medical Breakthroughs ETF 0.19
    BTEC D Principal Healthcare Innovators Index ETF 0.08
    AVSC C Avantis U.S. Small Cap Equity ETF 0.03
    View all Ns3 ETFs...
    Compare ETFs
    Compare GERM to AVSC Compare GERM to SBIO Compare LABD to BTEC

        Ns3 Stocks Recent News

        Date Stock Title
        May 8 ENTA Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 7 ENTA Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
        May 7 ENTA Q2 2024 Enanta Pharmaceuticals Inc Earnings Call
        May 7 ENTA Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
        May 7 ENTA Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
        May 7 ENTA Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript
        May 6 ENTA Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations
        May 6 ENTA Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
        May 6 ENTA Enanta Pharma GAAP EPS of -$1.47 misses by $0.17, revenue of $17.05M beats by $0.84M
        May 6 ENTA Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
        May 5 ENTA Enanta Pharma Q2 2024 Earnings Preview
        May 3 ENTA Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Chemical Compounds Cyclophilin Cyclopropanes HCV HCV Infection Hepatitis C Hepatitis C Virus Infection Infectious Diseases Medical Research Methicillin Pyrrolidines Staphylococcus Aureus Treatment Of Hepatitis Viruses
        Ns3

        Browse All Tags